These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 39137700)

  • 1. The immune thrombocytopenia paradox: Should we be concerned about thrombosis in ITP?
    Saldanha A; Colella MP; Villaça PR; Thachil J; Orsi FA
    Thromb Res; 2024 Sep; 241():109109. PubMed ID: 39137700
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thrombosis in immune thrombocytopenia - current status and future perspectives.
    Swan D; Newland A; Rodeghiero F; Thachil J
    Br J Haematol; 2021 Sep; 194(5):822-834. PubMed ID: 33822358
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Real-World Use of Fostamatinib in Patients with Immune Thrombocytopenia and Thrombotic Risk.
    Mehta AR; Kefela A; Toste C; Sweet D
    Acta Haematol; 2022; 145(2):221-228. PubMed ID: 34913873
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk-based and individualised management of bleeding and thrombotic events in adults with primary immune thrombocytopenia (ITP).
    Lambert C; Maitland H; Ghanima W
    Eur J Haematol; 2024 Apr; 112(4):504-515. PubMed ID: 38088207
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Older Adults and Immune Thrombocytopenia: Considerations for the Clinician.
    Crickx E; Mahévas M; Michel M; Godeau B
    Clin Interv Aging; 2023; 18():115-130. PubMed ID: 36726813
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thrombopoietin Receptor Agonists and Other Second-Line Therapies for Immune Thrombocytopenia: A Narrative Review With a Focus on Drug Access in Canada.
    Britto J; Holbrook A; Sun H; Cserti-Gazdewich C; Prokopchuk-Gauk O; Hsia C; Khamisa K; Yenson PR; Sholzberg M; Olney HJ; Shivakumar S; Jones D; Merkeley H; Costello J; Jamula E; Arnold DM
    Clin Invest Med; 2024 Mar; 47(1):13-22. PubMed ID: 38546381
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk factors of hospitalisation for thrombosis in adults with primary immune thrombocytopenia, including disease-specific treatments: a French nationwide cohort study.
    Lafaurie M; Maquet J; Baricault B; Ekstrand C; Christiansen CF; Linder M; Bahmanyar S; Nørgaard M; Sailler L; Lapeyre-Mestre M; Sommet A; Moulis G
    Br J Haematol; 2021 Nov; 195(3):456-465. PubMed ID: 34386974
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is ITP a thrombophilic disorder?
    Rodeghiero F
    Am J Hematol; 2016 Jan; 91(1):39-45. PubMed ID: 26547507
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current approaches for the diagnosis and management of immune thrombocytopenia.
    Gafter-Gvili A
    Eur J Intern Med; 2023 Feb; 108():18-24. PubMed ID: 36424271
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Addressing thrombosis concerns in immune thrombocytopenia: the role of fostamatinib in immune thrombocytopenia management.
    Provan D; Thachil J; Álvarez Román MT
    Expert Rev Hematol; 2024; 17(1-3):55-66. PubMed ID: 38369947
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thrombotic risk in patients with primary immune thrombocytopenia is only mildly increased and explained by personal and treatment-related risk factors.
    Ruggeri M; Tosetto A; Palandri F; Polverelli N; Mazzucconi MG; Santoro C; Gaidano G; Lunghi M; Zaja F; De Stefano V; Sartori R; Fazi P; Rodeghiero F;
    J Thromb Haemost; 2014 Aug; 12(8):1266-73. PubMed ID: 24942752
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Diagnostic approach and treatment of immune thrombocytopenia in adults].
    Kolonić SO; Patekar MB; Milunović V
    Acta Med Croatica; 2013 Mar; 67(1):3-11. PubMed ID: 24279250
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recent advances in understanding spleen tyrosine kinase (SYK) in human biology and disease, with a focus on fostamatinib.
    Cooper N; Ghanima W; Hill QA; Nicolson PL; Markovtsov V; Kessler C
    Platelets; 2023 Dec; 34(1):2131751. PubMed ID: 36331249
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immune thrombocytopenia.
    Bussel J; Cooper N; Boccia R; Zaja F; Newland A
    Expert Rev Hematol; 2021 Nov; 14(11):1013-1025. PubMed ID: 34720027
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment patterns and outcomes of second-line rituximab and thrombopoietin receptor agonists in adult immune thrombocytopenia: A Canadian retrospective cohort study.
    Podstawka J; Wall E; Bolster L; Patterson JM; Goodyear MD; Rydz N; Sun HL
    Thromb Res; 2022 Dec; 220():5-11. PubMed ID: 36257098
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current and emerging treatments for immune thrombocytopenia.
    Dou X; Yang R
    Expert Rev Hematol; 2019 Sep; 12(9):723-732. PubMed ID: 31237783
    [No Abstract]   [Full Text] [Related]  

  • 17. ITP and international guidelines: what do we know, what do we need?
    Rodeghiero F; Ruggeri M
    Presse Med; 2014 Apr; 43(4 Pt 2):e61-7. PubMed ID: 24656296
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An obvious antinomy, superior sagittal sinus thrombosis in a patient with immune thrombocytopenia: Case report and a review of literatures.
    Wang Y; Zhang G; Ding J
    Medicine (Baltimore); 2023 Mar; 102(13):e33412. PubMed ID: 37000101
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Refractory primary immune thrombocytopenia (ITP): current clinical challenges and therapeutic perspectives.
    Vianelli N; Auteri G; Buccisano F; Carrai V; Baldacci E; Clissa C; Bartoletti D; Giuffrida G; Magro D; Rivolti E; Esposito D; Podda GM; Palandri F
    Ann Hematol; 2022 May; 101(5):963-978. PubMed ID: 35201417
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immune Thrombocytopenic Purpura as a Hemorrhagic Versus Thrombotic Disease: An Updated Insight into Pathophysiological Mechanisms.
    Tărniceriu CC; Hurjui LL; Florea ID; Hurjui I; Gradinaru I; Tanase DM; Delianu C; Haisan A; Lozneanu L
    Medicina (Kaunas); 2022 Feb; 58(2):. PubMed ID: 35208534
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.